CXCL10 (IP-10) levels are higher in fatal CM in some cohorts, but reported effect sizes vary: in Ghana, associations with death were significant without reported AUC, whereas in an Indian cohort (n ≈ 6 HC/26 MM/26 CM survivors/12 CM non-survivors), ROC AUCs approached 1.0 but sample sizes were small, warranting caution [39,40]. This evidence concerns the gene CXCL10 and Miyoshi myopathy.